Sort
17,828 grants matching “crispr”
Genetic Factors of Bone Loss in Older Adults Taking Antidepressants
$391,939Timothy R Peterson · Washington University · R01 · FY2019 · AR
Thrombospondin-1 in normal and glaucomatous trabecular meshwork
$391,908Kate E Keller · Oregon Health & Science University · R01 · FY2024 · EY
Thrombospondin-1 in normal and glaucomatous trabecular meshwork
$391,908Kate E Keller · Oregon Health & Science University · R01 · FY2025 · EY
Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis
$391,906David B. Solit · Columbia University Health Sciences · P01 · FY2020 · CA
Project 1: Role of the H3K27 demethylase KDM6A in bladder cancer pathogenesis
$391,905David B. Solit · Columbia University Health Sciences · P01 · FY2021 · CA
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy
$391,721Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2025 · CA
Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy
$391,721Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2022 · CA
Defining the Critical Function and Regulation of NNMT in Breast Cancer Progression and Metastasis
$391,709Binhua P Zhou · University Of Kentucky · R01 · FY2025 · CA
Dissecting hybrid epithelial-mesenchymal states in head and neck cancer
$391,667Sidharth Venkata Puram · Washington University · R01 · FY2023 · DE
Administrative Core
$391,659Arlene H Sharpe · Harvard Medical School · U19 · FY2020 · AI
Analysis of chemical modulators for corneal endothelial dystrophies
$391,638Matilda F Chan · University Of California, San Francisco · R01 · FY2022 · EY
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
$391,638Deepak Ashok Lamba · University Of California, San Francisco · R01 · FY2022 · EY
Retroviral RLI immunomodulatory gene therapy for glioblastoma
$391,638Manish Aghi · University Of California, San Francisco · R01 · FY2024 · NS
PROMINENT - IARC
$391,529Paul Joseph Brennan · International Agency For Res On Cancer · OT2 · FY2022 · CA
Recombineering-based no-cleavage gene-editing toolkit for large-scale genome engineering and functional screening
$391,444Le Cong · Stanford University · R01 · FY2021 · GM
Molecular Basis of Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis
$391,282Jae U Jung · University Of Southern California · R01 · FY2015 · CA
Multi-view self-supervised deep learning for biological sequences and beyond
$391,250Dong Xu · University Of Missouri-Columbia · R35 · FY2023 · GM
Cell model for KSHV Infection and Genetic Manipulation
$391,250Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Cell model for KSHV Infection and Genetic Manipulation
$391,250Shou-Jiang Gao · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Multi-view self-supervised deep learning for biological sequences and beyond
$391,250Dong Xu · University Of Missouri-Columbia · R35 · FY2024 · GM
Multi-view self-supervised deep learning for biological sequences and beyond
$391,250Dong Xu · University Of Missouri-Columbia · R35 · FY2025 · GM
Discovering protein networks underlying regulated exocytosis
$391,250Jingshi Shen · University Of Colorado · R35 · FY2024 · GM
Extracellular vesicle-dependent RNA signaling in metabolism
$391,250Jingshi Shen · University Of Colorado · DP1 · FY2024 · DK
Functional evaluation of a new GWAS locus that links visceral adiposity and type 2 diabetes
$391,250Matthew Steinhauser · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Functional evaluation of a new GWAS locus that links visceral adiposity and type 2 diabetes
$391,250Matthew Steinhauser · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK